OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico
Samuel Ponce‐de‐León, Martha Torres, Luis Enrique Soto-Ramírez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 23
Samuel Ponce‐de‐León, Martha Torres, Luis Enrique Soto-Ramírez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 23
Showing 23 citing articles:
Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
Meera Madhavan, Adam Ritchie, Jeremy Aboagye, et al.
EBioMedicine (2022) Vol. 85, pp. 104298-104298
Open Access | Times Cited: 106
Meera Madhavan, Adam Ritchie, Jeremy Aboagye, et al.
EBioMedicine (2022) Vol. 85, pp. 104298-104298
Open Access | Times Cited: 106
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Shen Wang, Bo Liang, Weiqi Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 87
Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 51
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Nature (2023) Vol. 624, Iss. 7992, pp. 630-638
Closed Access | Times Cited: 51
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 47
Devaki Pilapitiya, Adam K. Wheatley, Hyon‐Xhi Tan
EBioMedicine (2023) Vol. 92, pp. 104585-104585
Open Access | Times Cited: 47
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
Raju Sunagar, Amit Kumar Singh, Sudeep Kumar
Vaccines (2023) Vol. 11, Iss. 4, pp. 849-849
Open Access | Times Cited: 23
COVID-19 vaccines: A comprehensive review of safety and efficacy
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Zhipeng Yan, Ming Yang, Ching‐Lung Lai
Elsevier eBooks (2025), pp. 685-777
Closed Access
Development and Scalable Production of Newcastle Disease Virus-Vectored Vaccines for Human and Veterinary Use
Julia Puppin Chaves Fulber, Amine Kamen
Viruses (2022) Vol. 14, Iss. 5, pp. 975-975
Open Access | Times Cited: 21
Julia Puppin Chaves Fulber, Amine Kamen
Viruses (2022) Vol. 14, Iss. 5, pp. 975-975
Open Access | Times Cited: 21
Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
Irene González‐Domínguez, José Luis Martínez, Stefan Slamanig, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 21
Irene González‐Domínguez, José Luis Martínez, Stefan Slamanig, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 21
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults
Ruiqi Zhang, Kwok‐Hung Chan, Pui Wang, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 723-723
Open Access | Times Cited: 7
Ruiqi Zhang, Kwok‐Hung Chan, Pui Wang, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 723-723
Open Access | Times Cited: 7
VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern
Kyle L. O’Donnell, Tylisha Gourdine, Paige Fletcher, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 435-435
Open Access | Times Cited: 10
Kyle L. O’Donnell, Tylisha Gourdine, Paige Fletcher, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 435-435
Open Access | Times Cited: 10
The Omicron-transformer: Rise of the subvariants in the age of vaccines
Travis Ren Teen Chia, Barnaby Edward Young, Po Ying Chia
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 11, pp. 712-729
Open Access | Times Cited: 10
Travis Ren Teen Chia, Barnaby Edward Young, Po Ying Chia
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 11, pp. 712-729
Open Access | Times Cited: 10
Phase II/III Double-Blind Study Evaluating Safety and Immunogenicity of a Single Intramuscular Booster Dose of the Recombinant SARS-CoV-2 Vaccine “Patria” (AVX/COVID-12) Using an Active Newcastle Disease Viral Vector (NDV) during the Omicron Outbreak in Healthy Adults with Elevated Baseline Antibody Titers from Prior COVID-19 and/or SARS-CoV-2 Vaccination
Constantino López‐Macías, Martha Torres, Brenda Armenta-Copca, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Constantino López‐Macías, Martha Torres, Brenda Armenta-Copca, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection
Deok‐Hwan Kim, Jiho Lee, Da-Ye Lee, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 921-921
Open Access | Times Cited: 1
Deok‐Hwan Kim, Jiho Lee, Da-Ye Lee, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 921-921
Open Access | Times Cited: 1
Mucosal delivery of RNA vaccines by Newcastle disease virus vectors
Adolfo García‐Sastre
Current Research in Immunology (2022) Vol. 3, pp. 234-238
Open Access | Times Cited: 6
Adolfo García‐Sastre
Current Research in Immunology (2022) Vol. 3, pp. 234-238
Open Access | Times Cited: 6
Antigen Delivery Systems: Past, Present, and Future
Hyun‐Jeong Ko, Yeon‐Jeong Kim
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 4, pp. 370-387
Open Access | Times Cited: 3
Hyun‐Jeong Ko, Yeon‐Jeong Kim
Biomolecules & Therapeutics (2023) Vol. 31, Iss. 4, pp. 370-387
Open Access | Times Cited: 3
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters
Rik L. de Swart, Olav S. de Leeuw, Nadia Oreshkova, et al.
Vaccine (2022) Vol. 40, Iss. 33, pp. 4676-4681
Open Access | Times Cited: 5
Rik L. de Swart, Olav S. de Leeuw, Nadia Oreshkova, et al.
Vaccine (2022) Vol. 40, Iss. 33, pp. 4676-4681
Open Access | Times Cited: 5
Mucosal delivery of nanovaccine strategy against COVID-19 and its variants
Junwoo Lee, Dongwoo Khang
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 7, pp. 2897-2925
Open Access | Times Cited: 5
Junwoo Lee, Dongwoo Khang
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 7, pp. 2897-2925
Open Access | Times Cited: 5
Intramuscular administration of recombinant Newcastle disease virus expressing SARS-CoV-2 spike protein protects hACE-2 TG mice against SARS-CoV-2 infection
Deok‐Hwan Kim, Jiho Lee, Sungsu Youk, et al.
Vaccine (2023) Vol. 41, Iss. 33, pp. 4787-4797
Open Access | Times Cited: 2
Deok‐Hwan Kim, Jiho Lee, Sungsu Youk, et al.
Vaccine (2023) Vol. 41, Iss. 33, pp. 4787-4797
Open Access | Times Cited: 2
Systematic In-Silico Evaluation of the Diagnostic Impact of Mpox Genome Variants in the Current Outbreak
Aastha Vatsyayan, V. R. Arvinden, Vinod Scaria
Molecular Diagnosis & Therapy (2022) Vol. 27, Iss. 2, pp. 275-280
Open Access | Times Cited: 3
Aastha Vatsyayan, V. R. Arvinden, Vinod Scaria
Molecular Diagnosis & Therapy (2022) Vol. 27, Iss. 2, pp. 275-280
Open Access | Times Cited: 3
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice
Irene González‐Domínguez, José Luis Martínez, Stefan Slamanig, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Irene González‐Domínguez, José Luis Martínez, Stefan Slamanig, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Inhalable SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Research Square (Research Square) (2023)
Open Access
Tong Ye, Zhouguang Jiao, Xin Li, et al.
Research Square (Research Square) (2023)
Open Access
Impacto del COVID-19 y su vacunación en el embarazo
Rebeca González-Reynoso, Jorge Valencia‐Ortega, Renata Saucedo
CIENCIA ergo sum (2023) Vol. 31
Open Access
Rebeca González-Reynoso, Jorge Valencia‐Ortega, Renata Saucedo
CIENCIA ergo sum (2023) Vol. 31
Open Access
La Ciencia detrás de la vacunas contra SARS CoV-2
E. J. Gutiérrez-Ruiz, Roger Iván Rodríguez‐Vivas, J.A. Rosado-Aguilar, et al.
Bioagrociencias (2022) Vol. 15, Iss. 2
Open Access
E. J. Gutiérrez-Ruiz, Roger Iván Rodríguez‐Vivas, J.A. Rosado-Aguilar, et al.
Bioagrociencias (2022) Vol. 15, Iss. 2
Open Access
